Zdrowie i gospodarka · 18/06/2015

FDA Releases Draft Guidance on Benefit-Risk Determinations for Medical Device Investigational Device Exemptions

The US Food and Drug Administration (FDA) has published a draft guidance document outlining key factors to consider when evaluating the benefits and risks of medical device investigational device exemptions (IDEs) for human clinical studies, aiming to provide clarity for FDA staff and IDE sponsors.